IP Library › Granted Patent US 6,911,437
Granted Patent B2
US 6,911,437 · App. 10/013,717 · Granted Jun 28, 2005

Saccharide derivatives especially useful in wound dressings

Assignees: The United States of America as represented by the Secretary of Agriculture; Virginia Commonwealth University
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,911,437
App. No.
10/013,717
Granted
Jun 28, 2005
Kind
B2
Abstract

Sequestrants and inhibitors of protease are applied to the wound site through the use of wound dressing based carrier systems to which they may be optionally ionically or covalently bound for the purpose of the initiation or enhancement of healing associated with chronic non-healing wounds.

Claims (37)

1. A saccharide derivative wherein:

a saccharide having anhydroglucose units is linked to “A” at the 2,3 or 6 position of the anhydroglucose units; and

“A” is:

methyl chloroformate,

pentafluoroethylketone,

dihydroxylketone,

levulinate,

alkyl ketone,

2,3 dialdehyde anhydroglucose,

glucose-6-citrate,

2,3 dialdehydo-glucose-6-citrate,

Leu,

Ile,

Val,

Me,

Val-Pro,

Pro-Val,

Ala-Pro-Val,

Val-Pro-Ala,

a tetrapeptide sequence wherein any of the following amino acids are the amino terminal residue of Ala-Pro-Val or Val-Pro-Ala; Lys, Arg, Trp, Phe, Gln, His, Tyr, and are linked through the amino- or COOH- termini of the peptide to the saccharide;

with the proviso that when A is an amino acid or peptide A may also be derivatized at its unbound amino- or COOH-terminus as an acid, carboxamide, alcohol, ester, ketone, aldehyde, ketomethylester, methyl chioroformate, pentafluoroethylketone or p-nitroanilide.

2. A saccharide derivative, wherein:

a saccharide is linked to a di-, tri-, or tetrapeptide “B”; and,

“B” is:

Leu,

Ile,

Val,

Nle;

Val-Pro,

Pro-Val,

Ala-Pro-Val

Val-Pro-Ala, or

a tetrapeptide sequence having an amino terminal residue selected from the group consisting of Ala-Pro-Val or Val-Pro-Ala; Lys, Arg, Trp, Phe, Gln, His, Tyr.

3. The saccharide derivative of claim 2 , wherein “B” is a peptide linked through an amino- or COOH- termini of the peptide to the saccharide through a salt bridge or embedded in saccharide formulation.

4. The saccharide derivative of claim 1 , wherein “A” is glucose-6-citrate.

5. The saccharide derivative of claim 1 , wherein “A” is levulinate.

6. The saccharide derivative of claim 1 , wherein the saccharide comprises a C 1 -C 8 alkyl ether, carboxylate, citrate, alkoxysuccinate, phosphate, sulfonate, alkyl amine, or thioalkyl.

Continuity (2)
Division 0951517200 · Feb 29, 2000
Related Publication 20020064551A1 · May 30, 2002